Precision Brain Therapy with MiNT™

Noninvasive, Multi-focal, image-guided Neuromodulation Therapy for the repair of damaged tracts and circuits anywhere in the brain

Problem

Treating Brain Disorders with Neuromodulation:

No solutions exist to safely repair damaged tracts and circuits anywhere in the brain

TMS (Transcranial Magnetic Stimulation):

Safe and effective, noninvasive therapy but can’t selectively and directly target tracts and circuits in the deep brain.

FUS (Focused Ultrasound Stimulation):

Noninvasive therapy for directly treating the deep brain, selectively and with high precision, but has potential safety (i.e., thermal) risks and requires active MRI-guidance.

DBS (Deep Brain Stimulation):

Invasive, surgical option involving electrode implants and surgical risk. Not multifocal and limited to specific indications and applications.

Existing therapies lack the ability to scale and safely, effectively, directly and comprehensively treat neural tracts and circuits anywhere in the brain

Solution

Multifocal image-guided Neuromodulation Therapy (MiNT™)

Not yet approved by the FDA and limited to investigational use only

MiNT™ has the potential to deliver biomarker-based treatments for a very wide range of mental health and neurological disorders

Feature 1

Image-guided treatment planning, with real-time targeting, and monitoring of location, dose, and response verification

Feature 1

Selective and Multifocal treatment of entire tracts and circuits anywhere in the brain

Feature 1

AI-assisted, personalization to improve response and remission with accelerated treatments

How it works

how it works

Why MiNT Stands Out?

A Comparison with Existing Brain Therapies

Effectiveness Score543210NoninvasiveDepthTargetingSafetyPrecision
Effectiveness Score543210CoverageMultifocalCapabilityAccessibilityScalability
TMS
FUS
DBS
MiNT
NoninvasiveDepth TargetingSafetyPrecisionCoverageMultifocal CapabilityAccessibilityScalability
TMS
FUS
DBS
MiNT

Why choose MiNT?

Not yet approved by the FDA and limited to investigational use only

Potential to deliver effective biomarker-based therapies for a wide range of mental health and neurological disorders with a safe, scalable, all-in-one solution that can be deployed in an office or mobile setting.

Patients Icon

Patients:

Improved outcomes, fewer medications, lower side effects, fewer visits.

Clinicians Icon

Clinicians:

Higher treatment efficacy, additional CPT codes for billing, potential as first-line therapy.

About Us

NeurTX is being spun-out from Weinberg Medical Physics (WMP), a medical device incubator located in Rockville, MD. WMP has expertise in medical imaging applications. Representative successes include:

  • Developed medical imaging devices used by millions of people.
  • FDA-cleared multiple devices for human use.
  • Licensed numerous patents to companies; sold medical device patent to Philips Medical.
  • Designed, built, and licensed an MRI system that has attained FDA clearance for guided therapy applications.

WMP has previously launched successful companies, including:

Promaxo, Radialis Medical, Brain Biosciences, and Longmile Veterinary Imaging.

Founders

Irving Weinberg, MD PhD

Irving Weinberg, MD PhD

Co-Founder and President

MedTech Expert, Radiologist, Entrepreneur

LinkedInLinkedIn profile
J. Ari Tuchman, PhD

J. Ari Tuchman, PhD

Co-Founder and Exec Chair

Business And Technical Expertise, Entrepreneur

LinkedInLinkedIn profile

Contact Us